Mi-Hyung Kim
Fortune : 1 M $ au 30/06/2026
Fortune : 1 M $ au 30/06/2026
Mi-Hyung Kim currently works at Anterogen Co., Ltd., as Co-Chief Executive Officer & Director and Morgan Stanley & Co. International Plc (South Korea), as Analyst.
Dr. Kim received her graduate degree from Seoul National University and undergraduate degree and doctorate degree from Ewha Womans University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ANTEROGEN CO., LTD. 0,93% | 10/07/2026 | 92 661 ( 0,93% ) | 1 M $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ANTEROGEN.CO.,LTD. | Directeur Général | - |
Morgan Stanley & Co. International Plc (South Korea)
Morgan Stanley & Co. International Plc (South Korea) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Seoul National University
Seoul National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Morgan Stanley & Co. International Plc (South Korea)
Morgan Stanley & Co. International Plc (South Korea) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Ewha Womans University
Ewha Womans University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anterogen Co., Ltd.
Anterogen Co., Ltd. BiotechnologyHealth Technology Develops and wholesales stem cell therapy medicine products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national